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Abstract
Background: Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with effective
antibiotics is recommended for shigellosis, but options become limited due to globally emerging resistance. One
of the mechanisms for the development of resistance utilizes integrons. This study described the antibiotic
susceptibility and the presence of class 1 and 2 integrons in S. flexneri and S. sonnei isolated in Uzbekistan.
Results: We studied 31 isolates of S. flexneri and 21 isolates of S. sonnei isolated in Uzbekistan between 1992 and
2007 for the susceptibility or resistance to ampicillin (Am), chloramphenicol (Cl), tetracycline (Te), co-trimoxazole
(Sxt), kanamycin (Km), streptomycin (Str), gentamicin (Gm), cefazolin (Czn), cefoperazone (Cpr), cefuroxime (Cur),
ceftazidime (Ctz), nalidixic acid (NA) and ciprofloxacin (Cip). Am/Str/Cl/Te and Am/Str/Cl/Te/Sxt resistance patterns
were found most frequently in S. flexneri. Single isolates were resistant to aminoglycoside, quinolones and
cephalosporins. The resistance patterns were different in the two species. Integrons were detected in 93.5% of S.
flexneri (29/31) and 81.0% of S. sonnei (17/21) isolates. In addition, 61.3% of S. flexneri (19/31) isolates and 19.0% of
S. sonnei (4/21) isolates carried both classes of integrons. In 29.0% of S. flexneri (9/31) isolates, only class 1 integrons
were identified. In S. flexneri isolates, the presence of class 1 integrons was associated with resistance to ampicillin
and chloramphenicol. Only Class 2 integrons were present in 61.9% of S. sonnei (13/21) isolates.
Conclusions: Our study documents antibiotic resistance among Shigella spp. in Uzbekistan. Ninety percent of
Shigella strains were resistant to previously used antibiotics. Differences among S. flexneri and S. sonnei isolates in
patterns of antimicrobial resistance to routinely used shigellosis antibiotics were observed. The majority of S. flexneri
were resistant to ampicillin, chloramphenicol, tetracycline and streptomycin. Class 1 and 2 integrons were widely
present in these Shigella strains. Resistance to ampicillin/chloramphenicol was associated with the presence of class
1 integrons. Though several mechanisms are possible, the resistance of Shigella isolates to ampicillin/
chloramphenicol may be associated with the expression of genes within class 1 integrons.
Background
Shigellosis is an acute enteric infection caused by Shigella
species and manifested by diarrhea. Shigellosis is endemic
to many developing countries, and also occurs in epi-
demics causing considerable morbidity and mortality
[1,2]. It was reported that more than 140 million cases of
shigellosis occurred worldwide, with 600,000 people
dying annually; 60% of the deaths were seen in children
under the age of 5 [3]. S. flexneri is the most commonly
isolated Shigella species in the developing world and the
most frequent cause of bacterial dysentery. In countries
with improved water supply and sanitation, the predomi-
nant species is S. sonnei. Antimicrobial agents are recom-
mended for the treatment of shigellosis; however,
increasing antimicrobial resistance in the Shigella spp.
has been reported worldwide [1,2]. Shigella strains have
obtained resistance to some of the most widely used anti-
biotics, resulting in reduced efficacies of antimicrobial
therapy [2,4-6]. One of the mechanisms of resistance
development is the horizontal transfer of genetic factors.
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genetic “islands”, which can transfer within a taxon [7,8].
Integrons, discovered in the 1980s, are able to horizon-
tally transfer genes; this is common for Enterobacteria-
ceae [9,10]. Integrons typically consist of an intI gene,
which encodes for integrase that catalyzes the incorpora-
tion or excision of gene cassettes by site-specific recom-
bination; a recombination site attI;a n dap r o m o t e r
responsible for the expression of inserted gene cassettes.
Integrons have been extensively studied in clinical envir-
onments due to their association with other mobile
genetic elements and multi-resistance phenotypes. There
are 4 classes of integrons that are distinguishable by the
integrase enzymes [11,12]. Class 1 and 2 integrons are
the most widespread among the Enterobacteriaceae,a n d
the correlation between the presence of integrons and
resistance to some antimicrobial agents has been demon-
strated [13]. There are several publications dedicated to
the study of integrons in Shigella spp. in different
regions; however, Central Asia was not covered in these
studies [14-16]. The widespread prevalence of poly-
resistant enteric bacteria necessitates the consistent sur-
veillance for antimicrobial resistance in Shigella spp. to
select effective antimicrobial agents. The purpose of this
study was to analyze antimicrobial susceptibility and the
presence of integrons in S. flexneri and S. sonnei isolated
in Uzbekistan.
Results and Discussion
We studied 31 isolates of S. flexneri and 21 isolates of S.
sonnei that were isolated in Uzbekistan between 1992 and
2007 for the susceptibility or resistance to ampicillin (Am),
chloramphenicol (Cl), tetracycline (Te), co-trimoxazole
(Sxt), kanamycin (Km), streptomycin (Str), gentamicin
(Gm), cefazolin (Czn), cefoperazone (Cpr), cefuroxime
(Cur), ceftazidime (Ctz), nalidixic acid (NA) and ciprofloxa-
cin (Cip). All Shigella isolates were resistant to streptomy-
cin. Most of the isolates were resistant to ampicillin,
chloramphenicol and tetracycline (Table 1). Among the S.
flexneri isolates, the most prevalent antimicrobial agent
resistance patterns were Am/Str/Cl/Te and Am/Str/Cl/Te/
Sxt. The most common S. sonnei antimicrobial agent resis-
tance patterns were Str, Str/Sxt/Te and Str/Te (Table 2).
Our data revealed differences in antimicrobial agent
resistance patterns among S. flexneri and S. sonnei for
the routinely used antimicrobial agents. The S. sonnei
isolates retained high sensitivity to ampicillin and chlor-
amphenicol but also exhibited higher resistance to co-
trimoxazole than the S. flexneri isolates did. However,
we identified one S. flexneri isolate that resistant to all
tested cephalosporins and one S. sonnei isolate resistant
to nalidixic acid and the cephalosporins.
Ampicillin, chloramphenicol and tetracycline were
the medications of choice in Uzbekistan for the
treatment of shigellosis. Currently, 90% of clinical iso-
lates of S. flexneri, the most common cause of shigello-
sis in Uzbekistan, have lost the natural susceptibility to
these medications. In addition, the appearance of
strains resistant to quinolones and cephalosporins,
which are recommended for treatment, is an emerging
problem that will require new approaches for antimi-
crobial therapy of shigellosis [17]. However, in our
study, we observed high in vitro activity of quinolones
and cephalosporins, making them the recommended
drugs of choice for the treatment of shigellosis in
Uzbekistan [2,18].
PCR studies for integrons revealed the presence of
both class 1 and class 2 integrons in S. flexneri and
S. sonnei (Tables 2 and 3). Integrons were detected in
93.5% of S. flexneri (29/31) and 81.0% of S. sonnei (17/
21) isolates. In 61.3% of S. flexneri (19/31) isolates, both
classes of integrons were identified, whereas only class 1
integrons were identified in 29.0% of S. flexneri (9/31)
isolates. Within the S. sonnei isolates, class 2 integrons
alone were identified in 61.9% of isolates (13/21) and
both class 1 and 2 integrons were identified in 19.0% of
isolates (4/21). The prevalence of class 2 integrons in S.
sonnei is in agreement with other published data
[16,19]. We did not identify S. sonnei isolates harboring
only class 1 integrons.
The high prevalence of class 1 and class 2 integrons in
this series of Shigella isolates as well as high prevalence
of resistance to the “older” antibiotics: ampicillin, chlor-
amphenicol, tetracycline, and streptomycin, makes sta-
tistical associations between phenotypic antimicrobial
resistance and the presence of integrons difficult to
interpret. In this series of isolates, for example, resis-
tance to streptomycin was detected in all 52 Shigella
isolates yet two S. flexneri and four S. sonnei isolates
had no integrons detected (Table 3). Yet, in all 28 S.
flexneri isolates where class 1 integrons were detected,
resistance to both chloramphenicol and ampicillin was
noted, and those 3 S. flexneri isolates lacking class 1
integrons were susceptible to both. Although cassettes
including resistance genes to ampicillin, chlorampheni-
col, and streptomycin have all been reported to com-
monly be present in integrons, in the absence of
sequencing augmented by conjugation experiments, it is
not possible to confirm the location of the active resis-
tance genes in integrons [11,15,18].
Conclusions
Our study confirms the circulation of Shigella flexneri
and Shigella sonnei strains that are resistant to widely
used antimicrobial agents and significant prevalence of
integrons in Shigella spp. circulating in Uzbekistan.
Though several mechanisms are possible, the resistance
of Shigella isolates to ampicillin/chloramphenicol may
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integrons. Cephalosporins and quinolones retain high
in vitro activity, but emergence of strains resistant to all
tested cephalosporins and other antimicrobials will
require continued routine monitoring of the antimicro-
bial resistance of Shigella spp. in Uzbekistan.
Methods
Isolates and serotyping
All Shigella isolates were provided by the “National Collec-
tion of Pathogens I-II Group” of the Ministry of Health of
the Republic of Uzbekistan. In total, 52 isolates of S. flexneri
and S. sonnei were studied (31 and 21 isolates, respectively).
All strains were isolated from stool samples of patients with
bacterial dysentery in Uzbekistan between 1992 and 2007.
The isolation and confirmation of Shigella species were per-
formed by following WHO recommendations [20]. Stool
samples were inoculated on Endo agar and Salmonella-Shi-
gella agar (SS agar) (Merck, Darmstadt, Germany). After
overnight incubation at 37°C, the Endo agar and SS agar
plates were checked for non-lactose-fermenting colonies.
Colonies characteristically resembling Shigella spp. were dif-
ferentiated from other non-lactose-fermenting enteric
pathogens by inoculating on Kligler iron agar (KIA agar)
(HiMedia Laboratories Pvt. Ltd., Mumbai, India) for typical
reactions [20]. Biochemical and serological typing of Shi-
gella spp. were performed by standard methods with speci-
fic antisera [21]. Prior to testing, each isolate was grown on
a Mueller-Hinton agar (MHA) plate (HiMedia Laboratories
Pvt. Ltd., Mumbai, India), incubated overnight at 37°C and
subsequently checked for auto-agglutination in saline. Spe-
cimens grown on the 18-20 hrs agar plate were used to
carry out agglutination tests according to the manufac-
turers’ instructions (SPBNIIVS, Sankt-Petersburg, Russian
Federation). In cases where no agglutination was observed
with any of the commercial antisera, the isolates were tested
for the presence of heat-labile inhibitory substances as
recommended [21]. Briefly, a colony was picked with loop
and dissolved in sterile normal saline to 0.5 McFarland
standards, heated at 100°C for 60 min, cooled and centri-
fuged; and resulting pellets were used for testing. For the
slide agglutination test, the agglutination of prepared
Table 1 Antimicrobial agent susceptibilities and MIC ranges of Shigella isolates from Uzbekistan
Antimicrobial
agent*
S. flexneri (n = 31) S. sonnei (n = 21) Breakpoint values (μg/ml)
||
Resistant
isolates
MIC
† (μg/ml) Resistant
isolates
MIC (μg/ml)
No (%) Range MIC50
‡ MIC90
§ No (%) Range MIC50 MIC90 RIS
Am 28(90.4) 2-512 256 512 1(4.8) 4-512 4 8 ≥32 16 ≤8
Cl 28(90.4) 4-256 128 256 1(4.8) 2-256 8 8 ≥32 16 ≤8
Te 29(93.5) 1-256 128 128 7(66.7) 1-256 128 256 ≥16 8 ≤4
Sxt 10(32.3) 0.5-128 2/38 128/2432 6(62) 0.5-128 128/2432 128/2432 ≥4/76 N/A ≤2/38
Km 2(6.5) 4-128 8 16 1(4.8) 4-64 8 8 ≥64 32 ≤16
Str 31(100) 64-256 256 256 21(100) 256 256 256 ≥64 32 ≤16
Gm 1(3.2) 2-32 4 4 2(9.5) 1-64 2 2 ≥16 8 ≤4
Czn 1(3.2) 0.5-32 2 4 0(0.0) 1-4 2 2 ≥32 16 ≤8
Cpr 1(3.2) 0.03-64 0.25 0.5 0(0.0) 0.12-0.5 0.12 0.25 ≥64 32 ≤16
Cur 1(3.2) 1-64 4 4 0(0.0) 1-4 4 4 ≥32 16 ≤8
Ctz 1(3.2) 0.06-64 0.12 0.25 0(0.0) 0.06-0.5 0.12 0.25 ≥32 16 ≤8
NA 0(0.0) 0.12-0.5 0.12 0.5 1(4.8) 0.12-32 0.12 0.25 ≥32 N/A ≤16
Cip 0(0.0) 0.008-0.016 0.008 0.016 1(4.8) 0.004-4 0.008 0.016 ≥42≤1
* Am = ampicillin, Cl = chloramphenicol, Te = tetracycline, Sxt = co-trimoxazole (trimethoprim- sulfamethoxazole), Km = kanamycin, Str = streptomycin, Gm =
gentamicin, Czn = cefazolin, Cpr = cefoperazone, Cur = cefuroxime, Ctz = ceftazidime, NA = nalidixic acid, Cip = ciprofloxacin
† MIC = Minimal inhibitory concentration; ‡ MIC50 = MIC inhibiting 50% of isolates; § MIC90 = MIC inhibiting 90% of isolates; || - intermediate resistant isolates
were considered as resistant
Table 2 Antimicrobial agent resistance patterns of
S. flexneri and S. sonnei isolates from Uzbekistan
Antimicrobial resistance pattern* S. flexneri
(n = 31)
No (%)
S. sonnei
(n = 21)
No (%)
Am/Cl/Str/Te 19 (61.3) 0 (0.0)
Am/Cl/Str/Sxt/Te 8 (25.8) 0 (0.0)
Am/Cl/Str/Sxt/Te/Czn/Cpr/Cur/Ctz/Gm/Km 1 (3.2) 0 (0.0)
Km/Str/Sxt 1 (3.2) 0 (0.0)
Str/Sxt 2 (6.4) 0 (0.0)
Str/Sxt/Te 0 (0.0) 10 (47.6)
Str 0 (0.0) 6 (28.6)
Str/Te 0 (0.0) 2 (9.5)
Am/Cl/Str/Sxt/Gm/Km 0 (0.0) 1 (4.8)
Gm/Str/Sxt/Te 0 (0.0) 1 (4.8)
NA/Cip/Str/Sxt/Te 0 (0.0) 1 (4.8)
* Am = ampicillin, Cl = chloramphenicol, Te = tetracycline, Sxt = co-
trimoxazole (trimethoprim- sulfamethoxazole), Km = kanamycin, Str =
streptomycin, Gm = gentamicin, Czn = cefazolin, Cpr = cefoperazone, Cur =
cefuroxime, Ctz = ceftazidime, NA = nalidixic acid, Cip = ciprofloxacin
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ground. The slide was tilted for 1 min and agglutination
scores were graded from 0 to 4 (0-no agglutination after 1
min, 1-weak agglutination after 3 min, 2-weak agglutination
after 1 min, 3-agglutination within 1 min, 4-visible rapid
agglutination right after addition of antisera). Only 3-4
scored agglutinated samples were considered as positive.
Antimicrobial susceptibility test
Antimicrobial susceptibility testing for Minimal Inhibi-
tory Concentration (MIC50 and MIC90) was performed
by a serial dilution method on solid agar, and the Mini-
mal Inhibitory Concentration was determined on MHA
according to Clinical and Laboratory Standards Institute
and the “Guidelines for susceptibility testing of microor-
ganisms to antimicrobial agents” (Ministry of Health,
Russian Federation) [22-24].
Briefly, MHA plates with different concentrations of
antimicrobial agents ((HiMedia Laboratories Pvt. Ltd.,
Mumbai, India) were prepared. Plates without antimi-
crobial agents were prepared for growth quality control.
MHA was poured into 90-mm plates on 3 mm depth.
Once prepared, plates were stored at 4°C and used
within 2 days. Approximately four colonies of overnight
incubated subcultures were inoculated into 4 ml of
Nutrient broth (HiMedia Laboratories Pvt. Ltd., Mum-
bai, India). After 4 h of incubation at 37°C, bacterial sus-
pension was adjusted to 0.5 McFarland standards. A
100 μl volume of this suspension was added to 900 μlo f
broth to produce a concentration of approximately 1 ×
10
7 CFU/ml. Plates were inoculated with metal loop
(approximately 1 μl of bacterial suspension resulting
spot of 5 mm in diameter) with 1 × 10
4 CFU/ml in final
inoculum. Plates were incubated for 18 h at 35°C under
atmospheric conditions. Growth was recorded positive if
at least one colony was observed at the inoculation site
[22-24]. Isolates were identified as resistant or suscepti-
ble (R/S). Intermediate susceptibility was categorized as
resistant. Reference strains of E. coli (ATCC 25922), S.
aureus (ATCC 25923) and P. aeruginosa (ATCC 27853)
were used for media and reagent quality control.
Table 3 Presence of integrons in Shigella isolates from
Uzbekistan and sensitivity/resistance to selected
antimicrobial agents
Isolate no. Species Antimicrobial agent* Integron
class
Am Cl Gm Km Sxt Te Str 1 2
1410 S. flexneri 1a R R S S S R R + -
1806 S. flexneri 1b R R S S S R R + +
2316 S. flexneri 1c R R S S S R R + -
1461/542 S. flexneri 2a R R S S S R R + -
2125/947 S. flexneri 2a R R S S S R R + -
2864/574 S. flexneri 2a R R S S R R R + +
3104/355 S. flexneri 2a R R S S R R R + +
3116/944 S. flexneri 2a R R S S R R R + +
3160/383 S. flexneri 2a R R S S R R R + -
4036/750 S. flexneri 2a R R S S S R R + +
33 S. flexneri 2a R R S S S R R + +
430 S. flexneri 2a R R S S S R R + -
525 S. flexneri 2a R R S S R R R + +
842 S. flexneri 2a R R S S R R R + +
1773 S. flexneri 2a R R S S S R R + +
1771 S. flexneri 2a R R S S S R R + +
1807 S. flexneri 2a R R S S S R R + +
1832 S. flexneri 2a R R S S R R R + +
2011 S. flexneri 2a R R S S S R R + +
2344 S. flexneri 2a R R S S S R R + +
2215/278 S. flexneri 2a S S S R R S R - +
737 S. flexneri 2a S S S S S R R - -
1875 S. flexneri 2b R R S S R R R + +
4297/499 S. flexneri 2b R R S S S R R + +
1874 S. flexneri 3a R R S S S R R + +
769 S. flexneri 3b R R S S S R R + -
1544 S. flexneri 4R R RRR R R++
2376 S. flexneri 4R R SSS R R+ -
3049/4396 S. flexneri 6R R SSS R R++
2078 S. flexneri 6R R SSS R R+ -
2126/4720 S. flexneri 6S S SSS S R- -
344/1899 S. sonnei SSS S SSR - -
346/459 S. sonnei SSS S RRR + +
358/477 S. sonnei SSS S SSR - +
333/1755 S. sonnei SSS S SRR + +
359/400 S. sonnei SSS S SSR - +
353/1950 S. sonnei SSS S RRR - +
766/601 S. sonnei SSS S SRR - -
1159/107 S. sonnei SSS S RRR - -
1201/1982 S. sonnei SSS S RRR - +
1316/152 S. sonnei SSS S SSR - +
1805/146 S. sonnei SSS S RRR + +
1849/760 S. sonnei SSS S SSR - +
2939/5116 S. sonnei SSS S SSR - -
1553/3 S. sonnei R R RRR S R+ +
1711/2 S. sonnei SSS S RRR - +
1745/3 S. sonnei SSS S RRR - +
4166/149 S. sonnei SSS S RRR - +
Table 3 Presence of integrons in Shigella isolates from
Uzbekistan and sensitivity/resistance to selected antimi-
crobial agents (Continued)
4336/671 S. sonnei SSS S RRR - +
4340/966 S. sonnei SSS S RRR - +
4342/1199 S. sonnei SSS S RRR - +
4345/199 S. sonnei SSR S RRR - +
* S = susceptible, R = resistant, * Am = ampicillin, Cl = chloramphenicol, Te =
tetracycline, Sxt = co-trimoxazole (trimethoprim- sulfamethoxazole), Km =
kanamycin, Str = streptomycin, Gm = gentamicin, Czn = cefazolin, Cpr =
cefoperazone, Cur = cefuroxime, Ctz = ceftazidime, NA = nalidixic acid, Cip =
ciprofloxacin
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Bacterial DNA was extracted from overnight incubation
of pure cultures by heating in a water bath at 96°C for
20 min. After centrifugation, supernatants were stored
at -20°C prior to PCR reactions. Primers (Operon Bio-
technologies GmbH, Cologne, Germany) int1L (5’-
ACATGTGATGGCGACGCACGA-3’)a n di n t 1 R( 5 ’-
ATTTCTGTCCTGGCTGGCGA-3’)w e r eu s e df o r
amplification of class 1 integrase (initial denaturation at
94°C for 10 min; 35 cycles of 94°C for 1 min, 60°C for 1
min, 72°C for 1 min; final elongation at 72°C for 10
min) [18]; Primers int2F (5’-GTAGCAAACGAGTGAC-
GAAATG-3’)a n di n t 2 R( 5 ’-CACGGATATGCGA-
CAAAAAGGT-3’) were used for amplification of class 2
integrase (initial denaturation at 95°C for 10 min; 35
cycles of 95°C for 50 sec, 58°C for 1 min, 72°C for
1 min10 sec; final elongation at 72°C for 10 min) [25].
The amplification was performed with the FailSafe™PCR
System (EPICENTRE Biotechnologies, Madison, WI,
USA) in a 25.0 μl reaction volume on a Thermo Px2
thermal cycler (Thermo Fisher Scientific Inc., Waltham,
MA, USA) following manufacturer recommendations.
PCR products were detected by ethidium bromine stain-
ing after electrophoresis in 1.5% agarose gels (SERVA
Electrophoresis GmbH, Heidelberg, Germany), with
DNA ladders (pUC19DNA/Mspl-Silex, Moscow, Russian
Federation; M100-Galart-diagnosticum, Moscow, Rus-
sian Federation) to determine band sizes. The expected
band sizes were approximately 569 bp and 789 bp for
the class 1 and class 2 integrase PCR products [18,25].
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